FIP1L1-PDGFRA fusion gene in T-lymphoblastic lymphoma: A case report.
Salhah AliYasmine Al-QattanWalaa AwnyAbdulaziz HamadahKaren PintoSalem AlShemmariPublished in: Cancer reports (Hoboken, N.J.) (2022)
FIP1L1-PDGFRA-positive T-LBL and myeloproliferative disorders have excellent response to low-dose treatment with (TKI) imatinib. Most patients achieve rapid and complete hematologic and molecular remission within weeks.
Keyphrases
- low dose
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic myeloid leukemia
- diffuse large b cell lymphoma
- tyrosine kinase
- peritoneal dialysis
- gene expression
- rheumatoid arthritis
- genome wide
- disease activity
- systemic lupus erythematosus
- transcription factor
- ulcerative colitis
- preterm birth
- sensitive detection